Blue Owl Capital Holdings LP Larimar Therapeutics, Inc. Transaction History
Blue Owl Capital Holdings LP
- $231 Million
- Q3 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 5,853,040 shares of LRMR stock, worth $19.8 Million. This represents 8.2% of its overall portfolio holdings.
Number of Shares
5,853,040
Previous 4,928,040
18.77%
Holding current value
$19.8 Million
Previous $14.2 Million
32.74%
% of portfolio
8.2%
Previous 7.71%
Shares
8 transactions
Others Institutions Holding LRMR
# of Institutions
156Shares Held
89MCall Options Held
6.44MPut Options Held
622K-
Deerfield Management Company, L.P. (Series C) New York, NY30.6MShares$103 Million1.84% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$20.4 Million0.34% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.9MShares$16.6 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA3.72MShares$12.6 Million2.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$11.5 Million6.65% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $146M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...